Adaptogens

Rhodiola Rosea: Benefits, Dosage & What the Science Says

Rhodiola rosea is a Tibetan and highland Chinese adaptogen whose salidroside and rosavin compounds regulate the stress response at the HPA and sympathoadrenal axes. Clinical trials support its use for burnout, mental fatigue, and altitude-related stress.

Last reviewed: Moderate evidence Rhodiola rosea L.

What Is Rhodiola Rosea?

High-altitude adaptogen for stress resistance and mental endurance

Evidence-Based Benefits

  • Mental fatigue and burnout resistance
  • Mood support and emotional resilience
  • Physical endurance and recovery

Recommended Dosage

300--600 mg daily of standardized extract (3% rosavins / 1% salidroside); take in the morning or before cognitively demanding work. Avoid late-evening dosing.

Safety, Side Effects & Interactions

Generally well tolerated; may cause mild activation or insomnia if taken late in the day; use with caution in bipolar disorder; no serious drug interactions confirmed at standard doses.

Works Well With

Research suggests Rhodiola Rosea may complement:

Traditional Use

Traditional Chinese Medicine
红景天 Hong Jing Tian
tonifies Qi and invigorates Blood calms the Heart and settles the mind clears Lung Heat activates Blood and dispels stasis

View herb profile on NaturalHerbLibrary.com →

References

  1. Rhodiola rosea for mental fatigue: a randomized controlled trial - PMID:19016404
  2. Salidroside and stress-axis regulation: a review - PMID:22643043
  3. Rhodiola rosea in burnout: pilot clinical study - PMID:22297986
  4. Adaptogenic effects of Rhodiola on physical performance - PMID:10839209

Last reviewed: June 6, 2026. For informational purposes only. See full disclaimer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

AI & Developer Endpoint

/data/supplements/rhodiola-rosea.json

This supplement profile ships machine-readable JSON-LD and a structured data endpoint for AI systems and developers.